Diagnostic News and Research

RSS

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

Biopsying the glands that produce saliva to test for germinal center-like formation when someone is diagnosed with primary Sjögren's Syndrome can predict later development of non-Hodgkin's lymphoma, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

RadNet third quarter revenue increases 5.0% to record $140.1 million

RadNet, Inc., a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 192 fully-owned and operated outpatient imaging centers, today reported financial results, including record revenues, for its third quarter of 2010.

9 Nov 2010

Mobile technology improves diagnosis and treatment for mothers, newborns and children

Simple mobile technology, like basic cell phones, can be used to save the lives of mothers in childbirth, and improve the care of newborns and children, reaching underserved populations in remote areas.

9 Nov 2010

Abbott, CHAI enter agreement to provide HIV testing to infants

Abbott and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI. A key focus of this cooperation will be sub-Saharan Africa, which the World Health Organization estimates to account for 90 percent of global HIV infections in children.

9 Nov 2010

Valley Anesthesiology Consultants' mobile services division receives AAAHC accreditation

VAC Mobile Services, a division of Valley Anesthesiology Consultants, has achieved accreditation by the Accreditation Association for Ambulatory Health Care (AAAHC). Valley is one of only 10 office-based anesthesia groups nationwide to receive AAAHC accreditation, and the only office-based anesthesia organization in Arizona currently accredited by AAAHC.

9 Nov 2010

Combination of optical and x-ray imaging may improve diagnostic accuracy of breast screening

By combining optical and x-ray imaging, radiologists may be better able to distinguish cancer from benign lesions in the breast, according to a new study published in the online edition and January issue of Radiology.

9 Nov 2010

SIMPONI injection improves inflammation, structural damage in RA patients

Magnetic resonance imaging (MRI) analyses from two Phase 3 clinical trials showed that once every four week subcutaneous injections of SIMPONI (golimumab) 50 mg plus methotrexate resulted in statistically significant improvements in markers of inflammation and structural damage in patients with active rheumatoid arthritis (RA) compared with placebo plus methotrexate.

9 Nov 2010

Merrimack receives $2.44 million under QTDP program to support cancer research

Merrimack Pharmaceuticals was awarded $2.44 million to support research on 10 of its cancer programs through the Qualifying Therapeutic Discovery Project, a grant program created as part of the Patient Protection and Affordable Care Act of 2010 to advance research in areas of unmet medical need.

9 Nov 2010

New Yorker examines global TB diagnostic challenges

The New Yorker examines the challenges associated with treating tuberculosis across the world and looks at whether a rapid diagnostic test could prevent millions of deaths from the disease.

8 Nov 2010

China Sky third quarter total revenue decreases 16.3% to $36.2 million

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China, today announced financial results for the third quarter of 2010.

8 Nov 2010

Raptor initiates dosing in DR Cysteamine Phase 2 clinical trial for Huntington's Disease

Raptor Pharmaceutical Corp., today announced that the first patient has been dosed in its Phase 2 clinical trial of DR Cysteamine for the potential treatment of Huntington's Disease. The Phase 2 clinical trial is being conducted under a previously announced collaboration agreement with The Centre Hospitalier Universitaire d'Angers ("CHU d'Angers"), which has commenced enrolling patients at eight clinical sites throughout France.

8 Nov 2010

Crescendo Bioscience launches multi-biomarker blood test for RA

Crescendo Bioscience announced today the commercial launch of Vectra DA, its first-in-class multi-biomarker blood test designed to aid physicians in managing patients with rheumatoid arthritis (RA). Vectra DA analyzes 12 key serum biomarkers to produce a single objective score that quantifies RA disease activity.

8 Nov 2010

CardioNet to acquire Biotel

CardioNet, Inc., a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, announced today that the Company entered into a definitive merger agreement with Biotel, Inc. to acquire all of the outstanding shares of Biotel for $11 million, or $3.84 per share, before adjustments for working capital. In connection with the merger agreement, the parties entered into a settlement agreement to dismiss the outstanding litigation between them, which will be effective as of the close of the merger.

8 Nov 2010

Chronic fatigue syndrome associated with maladaptive personality features and personality disorders

This study suggests that chronic fatigue syndrome is associated with an increased prevalence of maladaptive personality features and personality disorders. This might be associated with being noncompliant with treatment suggestions, displaying unhealthy behavioral strategies and lacking a stable social environment.

8 Nov 2010

Chindex 2011 second quarter revenue increases 18.6% to $45.2 million

Chindex International, Inc. a leading independent American provider of Western healthcare products and services in the People's Republic of China, today announced financial results for the second quarter and first half of fiscal year 2011, which ended September 30, 2010.

8 Nov 2010

Screening heavy smokers for lung cancer reduces chance of death, federal study finds

The Boston Globe: "Screening heavy smokers with sophisticated medical scanners modestly reduced their chance of dying from lung cancer, according to a federal study released yesterday that provides the first convincing evidence that testing could reduce the toll from the leading cause of cancer deaths. The preliminary findings from the National Cancer Institute were based on a gold-standard study that randomly assigned 53,000 current or former smokers without symptoms to be screened with a CT scanner or standard chest X-ray.

8 Nov 2010

ContextVision and Neusoft Medical enter strategic collaboration

ContextVision, the software imaging partner for the most recognized medical imaging manufacturers worldwide, today is pleased to announce that it has entered into a strategic collaboration with Neusoft Medical Systems Co., Ltd (Neusoft Medical, hereafter "NMS"), a leading provider of a broad range of medical equipment & IT solutions and healthcare services in China. NMS is a wholly-owned subsidiary of Neusoft Corporation, which is a leading IT solutions and services provider in China with revenue in excess of $600 million in 2009.

8 Nov 2010

NeoGenomics receives $374,479 grant under Patient Protection and Affordable Care Act

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported that it had been awarded two research and development grants totaling $374,479 from the US government under HR: 3590 - Patient Protection and Affordable Care Act (the "Act").

8 Nov 2010

Oragenics awarded $733,437 Federal Grant under PPACA Act

Florida-based biopharmaceutical company Oragenics, Inc. announced that it will receive a $733,437 Federal Grant as part of Congress's Patient Protection and Affordable Care Act of 2010.

8 Nov 2010

Genentech announces Phase II RG7204 clinical study results for metastatic melanoma tumors

Genentech, Inc., a member of the Roche Group today announced results from a Phase II clinical study of RG7204 (PLX4032), an investigational first-in-class molecule designed to selectively inhibit a cancer-causing, mutated form of the BRAF protein found in approximately half of metastatic melanoma tumors.

8 Nov 2010

Diagnostic News and Research

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

RadNet third quarter revenue increases 5.0% to record $140.1 million

Mobile technology improves diagnosis and treatment for mothers, newborns and children

Abbott, CHAI enter agreement to provide HIV testing to infants

Valley Anesthesiology Consultants' mobile services division receives AAAHC accreditation

Combination of optical and x-ray imaging may improve diagnostic accuracy of breast screening

SIMPONI injection improves inflammation, structural damage in RA patients

Merrimack receives $2.44 million under QTDP program to support cancer research

New Yorker examines global TB diagnostic challenges

China Sky third quarter total revenue decreases 16.3% to $36.2 million

Raptor initiates dosing in DR Cysteamine Phase 2 clinical trial for Huntington's Disease

Crescendo Bioscience launches multi-biomarker blood test for RA

CardioNet to acquire Biotel

Chronic fatigue syndrome associated with maladaptive personality features and personality disorders

Chindex 2011 second quarter revenue increases 18.6% to $45.2 million

Screening heavy smokers for lung cancer reduces chance of death, federal study finds

ContextVision and Neusoft Medical enter strategic collaboration

NeoGenomics receives $374,479 grant under Patient Protection and Affordable Care Act

Oragenics awarded $733,437 Federal Grant under PPACA Act

Genentech announces Phase II RG7204 clinical study results for metastatic melanoma tumors

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News